Status:
COMPLETED
The Efficacy of Hemp-containing Cream Versus Placebo in the Treatment of Uremic Pruritus
Lead Sponsor:
Thammasat University Hospital
Conditions:
Uremic Pruritus
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
Uremic pruritus is a significant burden on hemodialysis patients, affecting approximately 46% of individuals undergoing dialysis. Various mechanisms, including inadequate dialysis, increased uremic to...
Detailed Description
Eligible participants is randomly assigned in a 1:1 ratio to receive either a hemp-containing cream or a placebo. then, they are assessed for the severity of itching symptoms using the WI-NRS and thei...
Eligibility Criteria
Inclusion
- Adults ≥ 18 years old, diagnosed with end-stage kidney disease
- Undergoing thrice-weekly chronic hemodialysis for more than 90 days
- Exhibit a WI-NRS score of 3 or higher
Exclusion
- Ahistory of hemp allergy
- Pregnancy or breastfeeding
- Dermatologic diseases
- Adjustments to medications for controlling itch within the 14 days preceding the study.
Key Trial Info
Start Date :
September 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 8 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06159686
Start Date
September 15 2023
End Date
December 8 2023
Last Update
March 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thammasat
Pathum Thani, Thailand, 12120